+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Reduction of nocturnal diuresis and natriuresis during treatment of obstructive sleep apnea (OSA) with nasal continuous positive air pressure (nCPAP) correlates to cGMP excretion



Reduction of nocturnal diuresis and natriuresis during treatment of obstructive sleep apnea (OSA) with nasal continuous positive air pressure (nCPAP) correlates to cGMP excretion



Medizinische Klinik 86(6): 294



In ten patients with severe obstructive sleep apnea (OSA) profound changes in renal function could be demonstrated at night during nCPAP therapy. Natriuresis and diuresis decreased by about 50% while creatinine excretion rate and urinary osmolality did not change. We found parallel changes in the excretion of ANP's second messenger cyclic guanosine monophosphate (cGMP) in a dose-response-related manner to natriuresis respectively diuresis. These data are in agreement with recently demonstrated decrease of nocturnal plasma levels of atrial natriuretic peptide (ANP) during nCPAP therapy in apneic patients. This may be an indicator for an increased cardiac volume load during obstructive apnea. The decrease of diuresis, natriuresis and cGMP excretion demonstrate the beneficial effects of nCPAP treatment on the cardiovascular system. Therefore measurements of cGMP excretion may be a useful parameter to assess the cardiovascular function of apneic patients before and during treatment.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041200696

Download citation: RISBibTeXText

PMID: 1653395


Related references

Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea. Effects of nasal continuous positive airway pressure therapy. American Review of Respiratory Disease 145(6): 1367-1371, 1992

Risk of interrupting nocturnal nasal continuous positive airway pressure (nCPAP) in patients with obstructive sleep apnea. Deutsche Medizinische Wochenschrift 135(17): 868-869, 2010

Effects of nasal continuous positive airway pressure (NCPAP) on nocturnal renal function in obstructive sleep apnea syndrome (OSAS). Nihon Kyobu Shikkan Gakkai Zasshi 29(5): 573-577, 1991

Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment. American Journal of Hypertension 2(11 Pt 1): 847-852, 1989

Nocturnal blood pressure in sleep apnea effect of nasal continuous positive airway pressure ncpap. Annual Review of Chronopharmacology : 449-452, 1988

Nasal continuous positive airway pressure nCPAP treatment for obstructive sleep apnea, road traffic accidents and driving simulator performan A meta-analysis. 2012

Nasal continuous positive airway pressure (nCPAP) treatment for obstructive sleep apnea, road traffic accidents and driving simulator performance: a meta-analysis. Sleep Medicine Reviews 15(5): 301-310, 2011

Measurement of awake pharyngeal volumes pv using magnetic resonance imaging mri in patients with obstructive sleep apnea osa before and after treatment with nasal continuous positive airway pressure ncpap. American Review of Respiratory Disease 141(4 Part 2): A741, 1990

Impact of nasal continuous positive airway pressure ncpap on breathing route in patients with obstructive sleep apnea osa. American Review of Respiratory Disease 141(4 Part 2): A862, 1990

The effects of nasal continuous positive airway pressure ncpap on sleepiness and psychological functioning in obstructive sleep apnea osa. American Review of Respiratory Disease 145(4 Part 2): A168, 1992

The influence of nasal continuous positive airway pressure ncpap on apnea associated cardiac arrhythmias in the treatment of sleep apnea sa. Levi-Valensi, P And B Duron (Ed ) Colloque Inserm (Institute National De La Sante Et De La Recherche Medicale), Vol 167 Les Evenements Respiratoires Du Sommeil; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 167 Sleep Disorders And Respiration); Meeting, Amiens, France, November 19-20, 1987 Xvi+307p Les Editions Inserm: Paris, France; John Libbey And Co Ltd: London, England, Uk Illus Paper 239-240, 1988

Urinary excretion of cyclic gmp during sleep in obstructive sleep apnea patients with and without nasal continuous positive airway pressure treatment. Clinical Science 76(1): 31-38, 1989

Differential gene expression in the T-helper lymphocytes of obstructive sleep apnea patients treated with nasal continuous positive airway pressure (nCPAP). Medical Hypotheses 63(4): 630-632, 2004

Relationship between the reduction of hemoglobin and hematocrit, and nocturnal urine volume in obstructive sleep apnea patients after short-term nasal continuous positive airway pressure therapy. Togawa, K, Katayama, S, Hishikawa, Y, Ohto, Y, Horie, T Sleep apnea and rhonchopathy: 49-55, 1993

Treatment of sleep apnea syndrome: nCPAP (nasal continuous positive airway pressure) therapy. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 93(6): 1127-1132, 2004